Breaking News Instant updates and real-time market news.

VIVHY

Vivendi

$7.78 /

-0.19 (-2.38%)

15:07
09/27/22
09/27
15:07
09/27/22
15:07

Vivendi price target lowered to EUR 13.50 from EUR 13.60 at JPMorgan

JPMorgan analyst Daniel Kerven lowered the firm's price target on Vivendi to EUR 13.50 from EUR 13.60 and keeps an Overweight rating on the shares.

OTHER BREAKING NEWS FROM THE FLY

Syndicate
Grom Social Enterprises prices $5.0M public offering » 18:51
12/08/22
12/08
18:51
12/08/22
18:51
GROM

Grom Social Enterprises

/

+

Grom Social Enterprises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GROM Grom Social Enterprises
/

+

GROM Grom Social Enterprises
/

+

07/26/22 EF Hutton
Grom Social price target lowered to $2 from $5 at EF Hutton
01/13/22 EF Hutton
Grom Social Enterprises initiated with a Buy at EF Hutton
Hot Stocks
Black Stone Minerals CEO buys $839K in common stock » 18:47
12/08/22
12/08
18:47
12/08/22
18:47
BSM

Black Stone Minerals

$16.86 /

-0.395 (-2.29%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BSM Black Stone Minerals
$16.86 /

-0.395 (-2.29%)

BSM Black Stone Minerals
$16.86 /

-0.395 (-2.29%)

11/17/22 Piper Sandler
Black Stone Minerals price target raised to $19 from $18 at Piper Sandler
10/18/22 Piper Sandler
Black Stone Minerals price target raised to $18 from $17 at Piper Sandler
09/19/22 KeyBanc
KeyBanc starts Black Stone with Overweight, sees 'inflection point'
09/19/22 KeyBanc
Black Stone Minerals initiated with an Overweight at KeyBanc
BSM Black Stone Minerals
$16.86 /

-0.395 (-2.29%)

BSM Black Stone Minerals
$16.86 /

-0.395 (-2.29%)

Hot Stocks
Veeva director sells $1.64M in common stock » 18:46
12/08/22
12/08
18:46
12/08/22
18:46
VEEV

Veeva

$173.37 /

+8.14 (+4.93%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VEEV Veeva
$173.37 /

+8.14 (+4.93%)

VEEV Veeva
$173.37 /

+8.14 (+4.93%)

12/06/22 Cowen
Veeva initiated with a Market Perform at Cowen
12/05/22 KeyBanc
Veeva price target lowered to $210 from $220 at KeyBanc
12/05/22 Citi
Salesforce price target lowered to $164 from $170 at Citi
12/02/22 Morgan Stanley
Veeva assumed with an Equal Weight at Morgan Stanley
VEEV Veeva
$173.37 /

+8.14 (+4.93%)

VEEV Veeva
$173.37 /

+8.14 (+4.93%)

VEEV Veeva
$173.37 /

+8.14 (+4.93%)

Hot Stocks
Douglas Emmett cuts quarterly cash dividend to 19c per share from 28c » 18:45
12/08/22
12/08
18:45
12/08/22
18:45
DEI

Douglas Emmett

$15.39 /

+0.155 (+1.02%)

Douglas Emmett announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DEI Douglas Emmett
$15.39 /

+0.155 (+1.02%)

DEI Douglas Emmett
$15.39 /

+0.155 (+1.02%)

10/07/22 Piper Sandler
Douglas Emmett downgraded to Neutral from Overweight at Piper Sandler
09/27/22 Evercore ISI
Douglas Emmett downgraded to In Line from Outperform at Evercore ISI
06/30/22 Jefferies
Douglas Emmett price target lowered to $24 from $31 at Jefferies
06/22/22 Credit Suisse
Douglas Emmett initiated with an Outperform at Credit Suisse
DEI Douglas Emmett
$15.39 /

+0.155 (+1.02%)

DEI Douglas Emmett
$15.39 /

+0.155 (+1.02%)

Periodicals
Walmart to back Buy-Now-Pay-Later loan fintech venture, The Information reports » 18:45
12/08/22
12/08
18:45
12/08/22
18:45
WMT

Walmart

$148.79 /

+0.26 (+0.18%)

, AFRM

Affirm

$11.63 /

+0.285 (+2.51%)

, AAPL

Apple

$142.66 /

+1.7 (+1.21%)

Walmart (WMT) backed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WMT Walmart
$148.79 /

+0.26 (+0.18%)

AFRM Affirm
$11.63 /

+0.285 (+2.51%)

AAPL Apple
$142.66 /

+1.7 (+1.21%)

WMT Walmart
$148.79 /

+0.26 (+0.18%)

12/06/22 Bernstein
Walmart initiated with a Market Perform at Bernstein
12/01/22 Atlantic Equities
Walmart price target raised to $165 from $150 at Atlantic Equities
11/18/22 Gordon Haskett
Ross Stores upgraded to Buy at Gordon Haskett as off-price starts to turn corner
11/17/22 Truist
Target price target lowered to $151 from $165 at Truist
AFRM Affirm
$11.63 /

+0.285 (+2.51%)

07:46 Today Morgan Stanley
Block price target lowered to $66 from $67 at Morgan Stanley
07:46 Today Morgan Stanley
Affirm price target lowered to $46 from $52 at Morgan Stanley
11/29/22 UBS
Affirm initiated with a Neutral at UBS
11/10/22 DA Davidson
Affirm price target lowered to $32 from $50 at DA Davidson
AAPL Apple
$142.66 /

+1.7 (+1.21%)

12/07/22 Morgan Stanley
Morgan Stanley 'incrementally more conservative' on Apple's December quarter
12/06/22 UBS
Apple iPhone 14 Pro/Pro Max delivery times finally easing, says UBS
12/05/22 Wedbush
Apple shift out of China will not be easy, says Wedbush
12/02/22 Morgan Stanley
Morgan Stanley sees December quarter App Store forecast as 'conservative'
WMT Walmart
$148.79 /

+0.26 (+0.18%)

AFRM Affirm
$11.63 /

+0.285 (+2.51%)

AAPL Apple
$142.66 /

+1.7 (+1.21%)

WMT Walmart
$148.79 /

+0.26 (+0.18%)

AFRM Affirm
$11.63 /

+0.285 (+2.51%)

AAPL Apple
$142.66 /

+1.7 (+1.21%)

WMT Walmart
$148.79 /

+0.26 (+0.18%)

AFRM Affirm
$11.63 /

+0.285 (+2.51%)

AAPL Apple
$142.66 /

+1.7 (+1.21%)

WMT Walmart
$148.79 /

+0.26 (+0.18%)

AFRM Affirm
$11.63 /

+0.285 (+2.51%)

AAPL Apple
$142.66 /

+1.7 (+1.21%)

Hot Stocks
Douglas Emmett announces $300M share repurchase authorization » 18:44
12/08/22
12/08
18:44
12/08/22
18:44
DEI

Douglas Emmett

$15.39 /

+0.155 (+1.02%)

Douglas Emmett announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DEI Douglas Emmett
$15.39 /

+0.155 (+1.02%)

10/07/22 Piper Sandler
Douglas Emmett downgraded to Neutral from Overweight at Piper Sandler
09/27/22 Evercore ISI
Douglas Emmett downgraded to In Line from Outperform at Evercore ISI
06/30/22 Jefferies
Douglas Emmett price target lowered to $24 from $31 at Jefferies
06/22/22 Credit Suisse
Douglas Emmett initiated with an Outperform at Credit Suisse
DEI Douglas Emmett
$15.39 /

+0.155 (+1.02%)

DEI Douglas Emmett
$15.39 /

+0.155 (+1.02%)

Hot Stocks
Salesforce CEO: Planning for CRM to be second largest software company » 18:27
12/08/22
12/08
18:27
12/08/22
18:27
CRM

Salesforce

$130.16 /

-0.2848 (-0.22%)

In an interview on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$130.16 /

-0.2848 (-0.22%)

CRM Salesforce
$130.16 /

-0.2848 (-0.22%)

06:25 Today Baird
Baird downgrades Salesforce on macro, executive turnover concerns
05:29 Today Baird
Salesforce downgraded to Neutral from Outperform at Baird
12/05/22 KeyBanc
Veeva price target lowered to $210 from $220 at KeyBanc
12/05/22 Credit Suisse
Salesforce price target lowered to $225 from $250 at Credit Suisse
CRM Salesforce
$130.16 /

-0.2848 (-0.22%)

CRM Salesforce
$130.16 /

-0.2848 (-0.22%)

CRM Salesforce
$130.16 /

-0.2848 (-0.22%)

CRM Salesforce
$130.16 /

-0.2848 (-0.22%)

On The Fly
Fly Intel: After-Hours Movers » 18:00
12/08/22
12/08
18:00
12/08/22
18:00
DOCU

DocuSign

$43.78 /

+1.73 (+4.11%)

, AVGO

Broadcom

$531.27 /

+12.72 (+2.45%)

, PHR

Phreesia

$26.67 /

+0.7 (+2.70%)

, RH

RH

$266.37 /

+4.545 (+1.74%)

, MTN

Vail Resorts

$251.07 /

+4.69 (+1.90%)

, BBWI

Bath & Body Works

$42.16 /

-0.85 (-1.98%)

, JAZZ

Jazz Pharmaceuticals

$150.28 /

-0.93 (-0.62%)

, CURV

Torrid

$4.29 /

+0.385 (+9.86%)

, LULU

Lululemon

$375.51 /

+2.84 (+0.76%)

, CHWY

Chewy

$41.98 /

+0.77 (+1.87%)

, IOVA

Iovance Biotherapeutics

$7.17 /

-0.085 (-1.17%)

Check out this evening's…

ShowHide Related Items >><<
DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

PHR Phreesia
$26.67 /

+0.7 (+2.70%)

RH RH
$266.37 /

+4.545 (+1.74%)

MTN Vail Resorts
$251.07 /

+4.69 (+1.90%)

BBWI Bath & Body Works
$42.16 /

-0.85 (-1.98%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

CURV Torrid
$4.29 /

+0.385 (+9.86%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

12/06/22 Citi
DocuSign price target lowered to $59 from $76 at Citi
12/05/22 UBS
DocuSign price target lowered to $52 from $65 at UBS
12/05/22 Baird
DocuSign price target lowered to $50 from $70 at Baird
11/30/22 Jefferies
DocuSign initiated with a Hold at Jefferies
AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

12/05/22 Susquehanna
Broadcom price target lowered to $650 from $680 at Susquehanna
12/05/22 Piper Sandler
Broadcom price target lowered to $715 from $750 at Piper Sandler
10/27/22 Jefferies
Meta commentary positive for datacenter semi names, says Jefferies
10/18/22 Deutsche Bank
Broadcom price target lowered to $575 from $635 at Deutsche Bank
PHR Phreesia
$26.67 /

+0.7 (+2.70%)

10/13/22 DA Davidson
Phreesia initiated at Neutral at DA Davidson yesterday on valuation
10/12/22 DA Davidson
Phreesia initiated with a Neutral at DA Davidson
09/15/22 KeyBanc
Phreesia initiated with an Overweight at KeyBanc
09/08/22 Piper Sandler
Piper Sandler ups Phreesia price target to $33 following 'strong' Q2 beat
RH RH
$266.37 /

+4.545 (+1.74%)

11/21/22 Barclays
RH downgraded to Equal Weight from Overweight at Barclays
11/18/22 Wedbush
Wedbush downgrades RH on 'course-correction,' deteriorating macro
11/18/22 Wedbush
RH downgraded to Neutral from Outperform at Wedbush
10/31/22 Citi
RH price target lowered to $305 from $338 at Citi
MTN Vail Resorts
$251.07 /

+4.69 (+1.90%)

09/29/22 Truist
Vail Resorts price target lowered to $270 from $281 at Truist
09/29/22 Deutsche Bank
Vail Resorts price target lowered to $283 from $286 at Deutsche Bank
09/29/22 Barclays
Vail Resorts price target raised to $224 from $217 at Barclays
09/26/22 Stifel
Vail Resorts price target lowered to $228 from $273 at Stifel
BBWI Bath & Body Works
$42.16 /

-0.85 (-1.98%)

12/07/22 Argus
Bath & Body Works price target raised to $50 from $45 at Argus
11/28/22 Goldman Sachs
Goldman finds small crowds, more promotions over Black Friday weekend
11/18/22 Citi
Bath & Body Works price target raised to $50 from $48 at Citi
11/17/22 Morgan Stanley
Bath & Body Works price target raised to $76 from $72 at Morgan Stanley
JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

17:42 Today Goldman Sachs
Jazz Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs
11/30/22 Jefferies
Avadel upgraded to Buy at Jefferies after survey of sleep doctors
11/21/22 Needham
Avadel Pharmaceuticals price target raised to $9 from $8 at Needham
11/01/22 H.C. Wainwright
H.C. Wainwright downgrades Zymeworks on Jazz opt-out possibility
CURV Torrid
$4.29 /

+0.385 (+9.86%)

09/22/22 Morgan Stanley
Torrid price target lowered to $5 from $6.50 at Morgan Stanley
08/04/22 Baird
Torrid price target lowered to $7 from $9 at Baird
07/21/22 Goldman Sachs
Torrid price target lowered to $4 from $5.50 at Goldman Sachs
07/15/22 Cowen
Torrid downgraded to Market Perform at Cowen on low income consumer exposure
LULU Lululemon
$375.51 /

+2.84 (+0.76%)

12/07/22 Deutsche Bank
Lululemon price target raised to $450 from $434 at Deutsche Bank
12/06/22 Raymond James
Lululemon price target raised to $438 from $345 at Raymond James
12/05/22 Stifel
Lululemon price target raised to $450 from $400 at Stifel
12/05/22 Cowen
Lululemon price target raised to $542 from $535 at Cowen
CHWY Chewy
$41.98 /

+0.77 (+1.87%)

12/07/22 Wolfe Research
Chewy downgraded to Peer Perform from Outperform at Wolfe Research
11/28/22 Wedbush
Black Friday winners Include Best Buy, losers include Pets, says Wedbush
11/21/22 Deutsche Bank
Chewy price target raised to $50 from $40 at Deutsche Bank
11/15/22 MoffettNathanson
Chewy initiated with a Market Perform at MoffettNathanson
IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

17:09 Today Goldman Sachs
Iovance Biotherapeutics downgraded to Neutral from Buy at Goldman Sachs
11/21/22 JMP Securities
Iovance Biotherapeutics price target lowered to $21 from $25 at JMP Securities
11/20/22 Piper Sandler
Iovance Biotherapeutics price target lowered to $11 from $13 at Piper Sandler
11/18/22 Chardan
Iovance Biotherapeutics price target lowered to $29 from $30 at Chardan
DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

PHR Phreesia
$26.67 /

+0.7 (+2.70%)

RH RH
$266.37 /

+4.545 (+1.74%)

MTN Vail Resorts
$251.07 /

+4.69 (+1.90%)

BBWI Bath & Body Works
$42.16 /

-0.85 (-1.98%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

CURV Torrid
$4.29 /

+0.385 (+9.86%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

PHR Phreesia
$26.67 /

+0.7 (+2.70%)

RH RH
$266.37 /

+4.545 (+1.74%)

MTN Vail Resorts
$251.07 /

+4.69 (+1.90%)

BBWI Bath & Body Works
$42.16 /

-0.85 (-1.98%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

CURV Torrid
$4.29 /

+0.385 (+9.86%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

RH RH
$266.37 /

+4.545 (+1.74%)

BBWI Bath & Body Works
$42.16 /

-0.85 (-1.98%)

CURV Torrid
$4.29 /

+0.385 (+9.86%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

Periodicals
NHTSA seeks info on potentially defective air-bag inflators, WSJ reports » 17:54
12/08/22
12/08
17:54
12/08/22
17:54
F

Ford

$13.13 /

+0.015 (+0.11%)

, GM

General Motors

$38.21 /

+0.28 (+0.74%)

, HMC

Honda

$23.89 /

+0.02 (+0.08%)

, NSANY

Nissan

$6.82 /

+0.015 (+0.22%)

, TM

Toyota

$142.22 /

+0.52 (+0.37%)

, TSLA

Tesla

$173.44 /

-0.68 (-0.39%)

, DDAIF

Mercedes-Benz Group

/

+

, VWAGY

Volkswagen

$18.66 /

-0.18 (-0.96%)

, STLA

Stellantis

$14.85 /

-0.375 (-2.46%)

The U.S. National Highway…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
F Ford
$13.13 /

+0.015 (+0.11%)

GM General Motors
$38.21 /

+0.28 (+0.74%)

HMC Honda
$23.89 /

+0.02 (+0.08%)

NSANY Nissan
$6.82 /

+0.015 (+0.22%)

TM Toyota
$142.22 /

+0.52 (+0.37%)

TSLA Tesla
$173.44 /

-0.68 (-0.39%)

DDAIF Mercedes-Benz Group
/

+

VWAGY Volkswagen
$18.66 /

-0.18 (-0.96%)

STLA Stellantis
$14.85 /

-0.375 (-2.46%)

F Ford
$13.13 /

+0.015 (+0.11%)

12/05/22 Jefferies
Fox Factory price target raised to $135 from $120 at Jefferies
12/05/22 Jefferies
Polaris price target raised to $106 from $100 at Jefferies
11/30/22 Citi
Ford price target raised to $14 from $13 at Citi
10/27/22 Morgan Stanley
Ford decision to wind down Argo a positive, says Morgan Stanley
GM General Motors
$38.21 /

+0.28 (+0.74%)

11/18/22 Wedbush
GM's Investor Day event 'impressive,' says Wedbush
11/10/22 Wolfe Research
General Motors downgraded to Peer Perform from Outperform at Wolfe Research
10/26/22 Deutsche Bank
General Motors price target lowered to $35 from $36 at Deutsche Bank
10/26/22 JPMorgan
General Motors price target raised to $59 from $58 at JPMorgan
HMC Honda
$23.89 /

+0.02 (+0.08%)

03/03/22 Morgan Stanley
Other legacy automakers may follow Ford's lead, says Morgan Stanley
12/28/21 BofA
BofA sees December U.S. light vehicle sales down 20%
NSANY Nissan
$6.82 /

+0.015 (+0.22%)

11/28/22 JPMorgan
Nissan downgraded to Neutral from Overweight at JPMorgan
04/25/22 Citi
Nissan collaboration 'clear positive' for Luminar, says Citi
12/28/21 BofA
BofA sees December U.S. light vehicle sales down 20%
12/15/21 JPMorgan
Nissan upgraded to Overweight from Neutral at JPMorgan
TM Toyota
$142.22 /

+0.52 (+0.37%)

10/13/22 Citi
Toyota downgraded to Neutral at Citi on lower earnings outlook
10/13/22 Citi
Toyota downgraded to Neutral from Buy at Citi
10/06/22 UBS
Toyota downgraded to Neutral at UBS on lower profit forecasts
10/06/22 UBS
Toyota downgraded to Neutral from Buy at UBS
TSLA Tesla
$173.44 /

-0.68 (-0.39%)

13:21 Today Piper Sandler
Piper says Shanghai Gigafactory rumors 'easier to understand' amid weak November
12/07/22 Bernstein
Tesla may need to take additional price cuts in 2023, says Bernstein
12/05/22 Piper Sandler
If Tesla cuts production in China, it won't be due to competition, says Piper
11/29/22 Bernstein
Tesla risk/reward 'more balanced' after 48% drop, says Bernstein
DDAIF Mercedes-Benz Group
/

+

07/29/22 RBC Capital
Mercedes-Benz Group price target raised to EUR 90 from EUR 89 at RBC Capital
07/07/22 UBS
Mercedes-Benz Group price target lowered to EUR 80 from EUR 90 at UBS
05/18/22 Exane BNP Paribas
Tesla gets price target cut after losing Exane's 'EV World Cup'
05/17/22 Bernstein
Mercedes-Benz Group initiated with an Outperform at Bernstein
VWAGY Volkswagen
$18.66 /

-0.18 (-0.96%)

05:54 Today Exane BNP Paribas
Volkswagen downgraded to Underperform from Neutral at Exane BNP Paribas
12/07/22 Morgan Stanley
Volkswagen resumed with an Equal Weight at Morgan Stanley
11/08/22 BofA
Volkswagen upgraded to Buy from Neutral at BofA
11/08/22 Goldman Sachs
Volkswagen reinstated with a Neutral at Goldman Sachs
STLA Stellantis
$14.85 /

-0.375 (-2.46%)

11/30/22 Jefferies
Rio Tinto added to 'Franchise Picks' list at Jefferies
10/20/22 Nomura
Stellantis upgraded to Buy at Nomura amid 'appropriately paced' EV rollout
10/20/22 Nomura
Stellantis upgraded to Buy from Neutral at Nomura
10/14/22 Berenberg
Stellantis price target lowered to EUR 19 from EUR 21 at Berenberg
F Ford
$13.13 /

+0.015 (+0.11%)

GM General Motors
$38.21 /

+0.28 (+0.74%)

HMC Honda
$23.89 /

+0.02 (+0.08%)

TM Toyota
$142.22 /

+0.52 (+0.37%)

TSLA Tesla
$173.44 /

-0.68 (-0.39%)

DDAIF Mercedes-Benz Group
/

+

VWAGY Volkswagen
$18.66 /

-0.18 (-0.96%)

STLA Stellantis
$14.85 /

-0.375 (-2.46%)

F Ford
$13.13 /

+0.015 (+0.11%)

GM General Motors
$38.21 /

+0.28 (+0.74%)

HMC Honda
$23.89 /

+0.02 (+0.08%)

NSANY Nissan
$6.82 /

+0.015 (+0.22%)

TM Toyota
$142.22 /

+0.52 (+0.37%)

TSLA Tesla
$173.44 /

-0.68 (-0.39%)

DDAIF Mercedes-Benz Group
/

+

VWAGY Volkswagen
$18.66 /

-0.18 (-0.96%)

STLA Stellantis
$14.85 /

-0.375 (-2.46%)

F Ford
$13.13 /

+0.015 (+0.11%)

GM General Motors
$38.21 /

+0.28 (+0.74%)

HMC Honda
$23.89 /

+0.02 (+0.08%)

NSANY Nissan
$6.82 /

+0.015 (+0.22%)

TM Toyota
$142.22 /

+0.52 (+0.37%)

TSLA Tesla
$173.44 /

-0.68 (-0.39%)

DDAIF Mercedes-Benz Group
/

+

VWAGY Volkswagen
$18.66 /

-0.18 (-0.96%)

STLA Stellantis
$14.85 /

-0.375 (-2.46%)

F Ford
$13.13 /

+0.015 (+0.11%)

GM General Motors
$38.21 /

+0.28 (+0.74%)

TSLA Tesla
$173.44 /

-0.68 (-0.39%)

Recommendations
Rapt Therapeutics price target lowered to $33 from $34 at Piper Sandler » 17:48
12/08/22
12/08
17:48
12/08/22
17:48
RAPT

Rapt Therapeutics

$16.48 /

-0.31 (-1.85%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RAPT Rapt Therapeutics
$16.48 /

-0.31 (-1.85%)

RAPT Rapt Therapeutics
$16.48 /

-0.31 (-1.85%)

12/01/22 Goldman Sachs
Rapt Therapeutics initiated with a Buy at Goldman Sachs
11/14/22 H.C. Wainwright
Rapt Therapeutics price target lowered to $50 from $53 at H.C. Wainwright
11/10/22 Piper Sandler
Rapt Therapeutics price target raised to $34 from $30 at Piper Sandler
09/21/22 Capital One
Capital One starts Rapt with Overweight, sees 100% upside
RAPT Rapt Therapeutics
$16.48 /

-0.31 (-1.85%)

  • 18
    Nov
RAPT Rapt Therapeutics
$16.48 /

-0.31 (-1.85%)

Upgrade
Jazz Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs » 17:42
12/08/22
12/08
17:42
12/08/22
17:42
JAZZ

Jazz Pharmaceuticals

$150.28 /

-0.93 (-0.62%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

11/30/22 Jefferies
Avadel upgraded to Buy at Jefferies after survey of sleep doctors
11/21/22 Needham
Avadel Pharmaceuticals price target raised to $9 from $8 at Needham
11/01/22 H.C. Wainwright
H.C. Wainwright downgrades Zymeworks on Jazz opt-out possibility
10/24/22 Stifel
Zymeworks price target lowered to $18 from $21 at Stifel
JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

Syndicate
Faraday Future files to sell 84.2M shares of common stock for holders  17:35
12/08/22
12/08
17:35
12/08/22
17:35
FFIE

Faraday Future

/

+

 
ShowHide Related Items >><<
FFIE Faraday Future
/

+

FFIE Faraday Future
/

+

08/16/22 Benchmark
Faraday Future downgraded to Speculative Hold from Buy at Benchmark
FFIE Faraday Future
/

+

FFIE Faraday Future
/

+

FFIE Faraday Future
/

+

Hot Stocks
Chewy says now expects FY22 capex to come in slightly below 2.5% of sales » 17:35
12/08/22
12/08
17:35
12/08/22
17:35
CHWY

Chewy

$41.98 /

+0.77 (+1.87%)

Says ended the third…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHWY Chewy
$41.98 /

+0.77 (+1.87%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

12/07/22 Wolfe Research
Chewy downgraded to Peer Perform from Outperform at Wolfe Research
11/28/22 Wedbush
Black Friday winners Include Best Buy, losers include Pets, says Wedbush
11/21/22 Deutsche Bank
Chewy price target raised to $50 from $40 at Deutsche Bank
11/15/22 MoffettNathanson
Chewy initiated with a Market Perform at MoffettNathanson
CHWY Chewy
$41.98 /

+0.77 (+1.87%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

Hot Stocks
Airbus awarded $297.48M Army contract modification » 17:34
12/08/22
12/08
17:34
12/08/22
17:34
EADSY

Airbus

$29.04 /

+0.67 (+2.36%)

Airbus was awarded a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EADSY Airbus
$29.04 /

+0.67 (+2.36%)

EADSY Airbus
$29.04 /

+0.67 (+2.36%)

12/07/22 Kepler Cheuvreux
Airbus downgraded to Hold from Buy at Kepler Cheuvreux
12/06/22 Jefferies
Airbus price target lowered to EUR 132 from EUR 140 at Jefferies
11/07/22 Redburn
Safran initiated with a Buy at Redburn
11/07/22 Redburn
Airbus initiated with a Buy at Redburn
EADSY Airbus
$29.04 /

+0.67 (+2.36%)

EADSY Airbus
$29.04 /

+0.67 (+2.36%)

EADSY Airbus
$29.04 /

+0.67 (+2.36%)

Hot Stocks
Lockheed Martin awarded $328.53M Navy contract modification » 17:33
12/08/22
12/08
17:33
12/08/22
17:33
LMT

Lockheed Martin

$485.24 /

+3.89 (+0.81%)

Lockheed Martin was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

06:16 Today Citi
Lockheed Martin initiated with a Buy at Citi
12/06/22 Morgan Stanley
Textron's FLRAA win should be 'positively received,' says Morgan Stanley
12/05/22 Jefferies
Textron award estimated at $11 per share net present value, says Jefferies
12/05/22 Jefferies
Lockheed Martin price target raised to $525 from $500 at Jefferies
LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

Hot Stocks
Lockheed Martin awarded $2.22B Navy contract modification » 17:30
12/08/22
12/08
17:30
12/08/22
17:30
LMT

Lockheed Martin

$485.24 /

+3.89 (+0.81%)

Lockheed Martin was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

06:16 Today Citi
Lockheed Martin initiated with a Buy at Citi
12/06/22 Morgan Stanley
Textron's FLRAA win should be 'positively received,' says Morgan Stanley
12/05/22 Jefferies
Textron award estimated at $11 per share net present value, says Jefferies
12/05/22 Jefferies
Lockheed Martin price target raised to $525 from $500 at Jefferies
LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

Periodicals
Microsoft says Riot Games content coming to Game Pass December 12 » 17:25
12/08/22
12/08
17:25
12/08/22
17:25
MSFT

Microsoft

$247.41 /

+3.07 (+1.26%)

, TCEHY

Tencent

$40.88 /

+1.69 (+4.31%)

Microsoft (MSFT)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$247.41 /

+3.07 (+1.26%)

TCEHY Tencent
$40.88 /

+1.69 (+4.31%)

MSFT Microsoft
$247.41 /

+3.07 (+1.26%)

06:56 Today Citi
DoD contracts shows competitiveness of cloud industry, says Citi
12/07/22 BTIG
SentinelOne price target lowered to $20 from $25 at BTIG
12/01/22 BMO Capital
Okta price target raised to $69 from $58 at BMO Capital
12/01/22 Wedbush
Activision Blizzard added to Best Ideas List at Wedbush
TCEHY Tencent
$40.88 /

+1.69 (+4.31%)

11/02/22 Morgan Stanley
Tencent named a 'Catalyst Driven Idea' at Morgan Stanley
10/28/22 Barclays
Tencent price target lowered to $31 from $44 at Barclays
10/24/22 KGI Securities
Tencent downgraded to Neutral from Outperform at KGI Securities
09/22/22 Stifel
Ubisoft downgraded to Hold from Buy at Stifel
MSFT Microsoft
$247.41 /

+3.07 (+1.26%)

MSFT Microsoft
$247.41 /

+3.07 (+1.26%)

TCEHY Tencent
$40.88 /

+1.69 (+4.31%)

MSFT Microsoft
$247.41 /

+3.07 (+1.26%)

TCEHY Tencent
$40.88 /

+1.69 (+4.31%)

MSFT Microsoft
$247.41 /

+3.07 (+1.26%)

Conference/Events
Cantor Fitzgerald pharma/biotech analysts hold a dinner » 17:25
12/08/22
12/08
17:25
12/08/22
17:25
APLS

Apellis

$50.25 /

+2.575 (+5.40%)

, ISEE

Iveric bio

$21.23 /

+0.35 (+1.68%)

, JNJ

Johnson & Johnson

$177.19 /

-0.06 (-0.03%)

, NVS

Novartis

$91.58 /

-0.16 (-0.17%)

, AKTX

Akari Therapeutics

/

+

, BLTE

Belite Bio

$31.11 /

+0.705 (+2.32%)

, LCTX

Lineage Cell Therapeutics

$1.26 /

-0.05 (-3.82%)

, OCGN

Ocugen

$1.41 /

+0.035 (+2.55%)

, REGN

Regeneron

$765.12 /

+0.95 (+0.12%)

, RHHBY

Roche

$40.47 /

+0.52 (+1.30%)

, EYPT

EyePoint

$3.04 /

-0.005 (-0.16%)

, OCUL

Ocular Therapeutix

$2.76 /

-0.04 (-1.43%)

, CLSD

Clearside Biomedical

$1.16 /

+ (+0.00%)

, FDMT

4D Molecular

$24.51 /

+2.94 (+13.63%)

In conjunction with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APLS Apellis
$50.25 /

+2.575 (+5.40%)

ISEE Iveric bio
$21.23 /

+0.35 (+1.68%)

JNJ Johnson & Johnson
$177.19 /

-0.06 (-0.03%)

NVS Novartis
$91.58 /

-0.16 (-0.17%)

AKTX Akari Therapeutics
/

+

BLTE Belite Bio
$31.11 /

+0.705 (+2.32%)

LCTX Lineage Cell Therapeutics
$1.26 /

-0.05 (-3.82%)

OCGN Ocugen
$1.41 /

+0.035 (+2.55%)

REGN Regeneron
$765.12 /

+0.95 (+0.12%)

RHHBY Roche
$40.47 /

+0.52 (+1.30%)

EYPT EyePoint
$3.04 /

-0.005 (-0.16%)

OCUL Ocular Therapeutix
$2.76 /

-0.04 (-1.43%)

CLSD Clearside Biomedical
$1.16 /

+ (+0.00%)

FDMT 4D Molecular
$24.51 /

+2.94 (+13.63%)

APLS Apellis
$50.25 /

+2.575 (+5.40%)

11/18/22 Cowen
Apellis should trade to $70 upon pegectacoplan approval, says Cowen
11/10/22 Jefferies
Apellis downgraded to Hold at Jefferies after doctor survey
11/10/22 Jefferies
Iveric bio downgraded to Hold at Jefferies after doctor survey
11/10/22 Jefferies
Apellis downgraded to Hold from Buy at Jefferies
ISEE Iveric bio
$21.23 /

+0.35 (+1.68%)

11/10/22 Jefferies
Apellis downgraded to Hold at Jefferies after doctor survey
11/10/22 Jefferies
Iveric bio downgraded to Hold at Jefferies after doctor survey
11/10/22 Jefferies
Iveric bio downgraded to Hold from Buy at Jefferies
10/17/22 B. Riley
Iveric bio upgraded to Neutral at B. Riley after competitor in GA 'disappoints'
JNJ Johnson & Johnson
$177.19 /

-0.06 (-0.03%)

12/07/22 Piper Sandler
Horizon Therapeutics price target raised to $110 from $90 at Piper Sandler
12/01/22 Jefferies
Horizon Therapeutics price target raised to $125 from $101 at Jefferies
12/01/22 Morgan Stanley
Johnson & Johnson price target raised to $178 from $170 at Morgan Stanley
11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
NVS Novartis
$91.58 /

-0.16 (-0.17%)

12/05/22 Stifel
Novartis upgraded to Buy from Hold at Stifel
10/26/22 JPMorgan
Novartis price target lowered to CHF 78 from CHF 81 at JPMorgan
10/14/22 Barclays
Novartis price target lowered to CHF 75 from CHF 85 at Barclays
10/07/22 Deutsche Bank
Novartis price target lowered to CHF 70 from CHF 75 at Deutsche Bank
AKTX Akari Therapeutics
/

+

12/05/22 H.C. Wainwright
Akari Therapeutics initiated with a Buy at H.C. Wainwright
11/01/22 Alliance Global Partners
Akari Therapeutics initiated with a Buy at Alliance Global Partners
BLTE Belite Bio
$31.11 /

+0.705 (+2.32%)

08/01/22 H.C. Wainwright
Belite Bio initiated with a Buy at H.C. Wainwright
07/01/22 Benchmark
Belite Bio initiated with a Buy at Benchmark
LCTX Lineage Cell Therapeutics
$1.26 /

-0.05 (-3.82%)

11/01/22 Baird
Baird starts Lineage Cell Therapeutics with an Outperform, $5 price target
11/01/22 Baird
Lineage Cell Therapeutics initiated with an Outperform at Baird
06/14/22 B. Riley
B. Riley starts 'deep value play' Lineage Cell with Buy, $4 target
06/14/22 B. Riley
Lineage Cell Therapeutics initiated with a Buy at B. Riley
OCGN Ocugen
$1.41 /

+0.035 (+2.55%)

08/23/22 Mizuho
Ocugen initiated with a Buy at Mizuho
08/15/22 H.C. Wainwright
Ocugen price target lowered to $6 from $7 at H.C. Wainwright
06/15/22 Roth Capital
Ocugen resumed at Buy at Roth Capital on COVAXIN and OCU400 potential
06/15/22 Roth Capital
Ocugen resumed at Buy from Neutral at Roth Capital
REGN Regeneron
$765.12 /

+0.95 (+0.12%)

11/09/22 RBC Capital
Regeneron Eylea IPR losses 'mostly anticipated,' says RBC Capital
11/09/22 Truist
Regeneron price target raised to $856 from $790 at Truist
11/03/22 Piper Sandler
Regeneron price target lowered to $765 from $775 at Piper Sandler
10/31/22 EF Hutton
Regeneron initiated with a Buy at EF Hutton
RHHBY Roche
$40.47 /

+0.52 (+1.30%)

12/07/22 Morgan Stanley
Roche price target lowered to CHF 330 from CHF 350 at Morgan Stanley
12/02/22 BofA
Hookipa Pharma downgraded to Underperform from Buy at BofA
11/29/22 Guggenheim
Roche bladder cancer indication withdrawal positive for Seagen, says Guggenheim
11/15/22 Truist
Biogen price target raised to $350 from $265 at Truist
EYPT EyePoint
$3.04 /

-0.005 (-0.16%)

08/31/22 Cantor Fitzgerald
Cantor says EyePoint negative stock reaction to 8-K 'overdone'
08/04/22 H.C. Wainwright
EyePoint price target raised to $25 from $24 at H.C. Wainwright
07/07/22 Chardan
EyePoint initiated with a Buy at Chardan
OCUL Ocular Therapeutix
$2.76 /

-0.04 (-1.43%)

11/08/22 H.C. Wainwright
Ocular Therapeutix price target lowered to $9 from $10 at H.C. Wainwright
11/08/22 Raymond James
Ocular Therapeutix price target lowered to $14 from $29 at Raymond James
09/29/22 Piper Sandler
Ocular Therapeutix data 'paint a compelling profile,' says Piper Sandler
09/27/22 Piper Sandler
Ocular Therapeutix hit/beat on Phase I study expectations, says Piper Sandler
CLSD Clearside Biomedical
$1.16 /

+ (+0.00%)

11/10/22 Needham
Clearside Biomedical upgraded to Buy from Hold at Needham
11/10/22 H.C. Wainwright
Clearside Biomedical price target raised to $6 from $5 at H.C. Wainwright
11/09/22 Stifel
Clearside Biomedical upgraded to Buy at Stifel after positive trial readout
11/09/22 Stifel
Clearside Biomedical upgraded to Buy from Hold at Stifel
FDMT 4D Molecular
$24.51 /

+2.94 (+13.63%)

11/18/22 H.C. Wainwright
4D Molecular initiated with a Buy at H.C. Wainwright
11/15/22 Goldman Sachs
4D Molecular upgraded to Buy from Neutral at Goldman Sachs
11/14/22 BofA
4D Molecular price target raised to $25 from $15 at BofA
11/14/22 Evercore ISI
4D Molecular price target raised to $45 from $32 at Evercore ISI
ISEE Iveric bio
$21.23 /

+0.35 (+1.68%)

JNJ Johnson & Johnson
$177.19 /

-0.06 (-0.03%)

NVS Novartis
$91.58 /

-0.16 (-0.17%)

AKTX Akari Therapeutics
/

+

LCTX Lineage Cell Therapeutics
$1.26 /

-0.05 (-3.82%)

OCGN Ocugen
$1.41 /

+0.035 (+2.55%)

REGN Regeneron
$765.12 /

+0.95 (+0.12%)

RHHBY Roche
$40.47 /

+0.52 (+1.30%)

EYPT EyePoint
$3.04 /

-0.005 (-0.16%)

OCUL Ocular Therapeutix
$2.76 /

-0.04 (-1.43%)

CLSD Clearside Biomedical
$1.16 /

+ (+0.00%)

FDMT 4D Molecular
$24.51 /

+2.94 (+13.63%)

  • 01
    Dec
  • 29
    Apr
  • 24
    Mar
  • 23
    Feb
JNJ Johnson & Johnson
$177.19 /

-0.06 (-0.03%)

NVS Novartis
$91.58 /

-0.16 (-0.17%)

REGN Regeneron
$765.12 /

+0.95 (+0.12%)

RHHBY Roche
$40.47 /

+0.52 (+1.30%)

APLS Apellis
$50.25 /

+2.575 (+5.40%)

ISEE Iveric bio
$21.23 /

+0.35 (+1.68%)

JNJ Johnson & Johnson
$177.19 /

-0.06 (-0.03%)

NVS Novartis
$91.58 /

-0.16 (-0.17%)

BLTE Belite Bio
$31.11 /

+0.705 (+2.32%)

LCTX Lineage Cell Therapeutics
$1.26 /

-0.05 (-3.82%)

OCGN Ocugen
$1.41 /

+0.035 (+2.55%)

REGN Regeneron
$765.12 /

+0.95 (+0.12%)

RHHBY Roche
$40.47 /

+0.52 (+1.30%)

OCUL Ocular Therapeutix
$2.76 /

-0.04 (-1.43%)

FDMT 4D Molecular
$24.51 /

+2.94 (+13.63%)

APLS Apellis
$50.25 /

+2.575 (+5.40%)

ISEE Iveric bio
$21.23 /

+0.35 (+1.68%)

JNJ Johnson & Johnson
$177.19 /

-0.06 (-0.03%)

NVS Novartis
$91.58 /

-0.16 (-0.17%)

OCGN Ocugen
$1.41 /

+0.035 (+2.55%)

REGN Regeneron
$765.12 /

+0.95 (+0.12%)

Hot Stocks
Fiesta Restaurant names Dirk Montgomery as interim CEO » 17:22
12/08/22
12/08
17:22
12/08/22
17:22
FRGI

Fiesta Restaurant

$6.53 /

+0.145 (+2.27%)

Fiesta Restaurant…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FRGI Fiesta Restaurant
$6.53 /

+0.145 (+2.27%)

Earnings
Chewy raises FY22 revenue view to $10.02B-$10.04B from $9.9B-$10B » 17:19
12/08/22
12/08
17:19
12/08/22
17:19
CHWY

Chewy

$41.98 /

+0.77 (+1.87%)

Consensus $9.99B. Sees…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHWY Chewy
$41.98 /

+0.77 (+1.87%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

12/07/22 Wolfe Research
Chewy downgraded to Peer Perform from Outperform at Wolfe Research
11/28/22 Wedbush
Black Friday winners Include Best Buy, losers include Pets, says Wedbush
11/21/22 Deutsche Bank
Chewy price target raised to $50 from $40 at Deutsche Bank
11/15/22 MoffettNathanson
Chewy initiated with a Market Perform at MoffettNathanson
CHWY Chewy
$41.98 /

+0.77 (+1.87%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

Earnings
Chewy sees Q4 revenue $2.63B-$2.65B, consensus $2.64B » 17:16
12/08/22
12/08
17:16
12/08/22
17:16
CHWY

Chewy

$41.98 /

+0.77 (+1.87%)

Guidance taken from Q3…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHWY Chewy
$41.98 /

+0.77 (+1.87%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

12/07/22 Wolfe Research
Chewy downgraded to Peer Perform from Outperform at Wolfe Research
11/28/22 Wedbush
Black Friday winners Include Best Buy, losers include Pets, says Wedbush
11/21/22 Deutsche Bank
Chewy price target raised to $50 from $40 at Deutsche Bank
11/15/22 MoffettNathanson
Chewy initiated with a Market Perform at MoffettNathanson
CHWY Chewy
$41.98 /

+0.77 (+1.87%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

Conference/Events
GitLab management to meet with KeyBanc » 17:16
12/08/22
12/08
17:16
12/08/22
17:16
GTLB

GitLab

$47.47 /

+4.84 (+11.35%)

Meeting to be held with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTLB GitLab
$47.47 /

+4.84 (+11.35%)

GTLB GitLab
$47.47 /

+4.84 (+11.35%)

12/06/22 Piper Sandler
GitLab price target lowered to $60 from $67 at Piper Sandler
11/29/22 BofA
BofA ups GitLab target to $78 with survey suggesting Q3 beat
11/28/22 RBC Capital
GitLab price target lowered to $55 from $75 at RBC Capital
11/28/22 Piper Sandler
GitLab remains a top idea with $67 target at Piper Sandler
GTLB GitLab
$47.47 /

+4.84 (+11.35%)

GTLB GitLab
$47.47 /

+4.84 (+11.35%)

GTLB GitLab
$47.47 /

+4.84 (+11.35%)

Conference/Events
Ryder management to meet with KeyBanc » 17:14
12/08/22
12/08
17:14
12/08/22
17:14
R

Ryder

$84.91 /

-0.62 (-0.72%)

Meeting to be held with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
R Ryder
$84.91 /

-0.62 (-0.72%)

R Ryder
$84.91 /

-0.62 (-0.72%)

09/28/22 Stifel
Offer for Ryder well above $86 seems 'unlikely,' says Stifel
06/06/22 Stifel
Ryder price target raised to $90 from $80 at Stifel
06/06/22 Wolfe Research
Ryder upgraded to Peer Perform from Underperform at Wolfe Research
06/06/22 Wells Fargo
Ryder price target raised to $81 from $68 at Wells Fargo
R Ryder
$84.91 /

-0.62 (-0.72%)

R Ryder
$84.91 /

-0.62 (-0.72%)

R Ryder
$84.91 /

-0.62 (-0.72%)

Conference/Events
Steris management to meet virtually with KeyBanc » 17:09
12/08/22
12/08
17:09
12/08/22
17:09
STE

Steris

$190.35 /

+5.06 (+2.73%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STE Steris
$190.35 /

+5.06 (+2.73%)

STE Steris
$190.35 /

+5.06 (+2.73%)

11/11/22 KeyBanc
Steris price target lowered to $210 from $240 at KeyBanc
09/23/22 Needham
Steris cut to Hold at Needham on ethylene oxide exposure liability concerns
09/23/22 Needham
Steris downgraded to Hold from Buy at Needham
08/04/22 JMP Securities
Steris price target lowered to $250 from $270 at JMP Securities
STE Steris
$190.35 /

+5.06 (+2.73%)

STE Steris
$190.35 /

+5.06 (+2.73%)

STE Steris
$190.35 /

+5.06 (+2.73%)

Downgrade
Iovance Biotherapeutics downgraded to Neutral from Buy at Goldman Sachs » 17:09
12/08/22
12/08
17:09
12/08/22
17:09
IOVA

Iovance Biotherapeutics

$7.17 /

-0.085 (-1.17%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

11/21/22 JMP Securities
Iovance Biotherapeutics price target lowered to $21 from $25 at JMP Securities
11/20/22 Piper Sandler
Iovance Biotherapeutics price target lowered to $11 from $13 at Piper Sandler
11/18/22 Chardan
Iovance Biotherapeutics price target lowered to $29 from $30 at Chardan
11/18/22 Oppenheimer
Iovance price target lowered to $25 from $27 at Oppenheimer
IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.